TRIM37 promoted lung cancer progression by activating the PI3K/AKT and NF-κB pathways, and TRIM37 suppression resulted in significant decreases in tumorigenesis in vivo [25,30]. This evidence concerns the gene NFKB1 and lung carcinoma.